申请人:GlycoMimetics, Inc.
公开号:US10519181B2
公开(公告)日:2019-12-31
Compounds, compositions, and methods for treatment and/or prevention of cancer and inflammatory diseases, and for releasing cells such as stem cells (e.g., bone marrow progenitor cells) into circulating blood and enhancing retention of the cells in the blood are disclosed. For example, heterobifunctional compounds that inhibit both E-selectins and CXCR4 chemokine receptors are described and pharmaceutical compositions comprising at least one of the same.
本文公开了用于治疗和/或预防癌症和炎症性疾病,以及将干细胞(如骨髓祖细胞)等细胞释放到循环血液中并增强细胞在血液中的存留的化合物、组合物和方法。例如,描述了同时抑制E-选择素和CXCR4趋化因子受体的异官能化合物,以及包含至少一种相同化合物的药物组合物。